deltatrials
Completed PHASE2 INTERVENTIONAL NCT00109460

Tobacco Cessation Field Study for Adults in Recovery - 1

Tobacco Cessation Clinical Field Study for Adults in Alcohol Abuse Recovery

Sponsor: Inflexxion, Inc.

Conditions Tobacco Use Disorder
Interventions Tobacco Use Disorder
Updated 5 times since 2017 Last updated: May 11, 2015 Started: Mar 31, 2003 Primary completion: Mar 31, 2005 Completion: Mar 31, 2005
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00109460, this PHASE2 trial focuses on Tobacco Use Disorder and remains completed. Sponsored by Inflexxion, Inc., it has been updated 5 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Mar 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Inflexxion, Inc.
  • National Institute on Drug Abuse (NIDA)
Data source: Inflexxion, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations